Special Issue "MRI Contrast Agents"
Deadline for manuscript submissions: 30 June 2019
Dr. Célia S. Bonnet
CNRS Centre National de la Recherche Scientifique, Centre de Biophysique Moléculaire, Paris, France
Website | E-Mail
Interests: contrast agents for MRI, molecular imaging, paramagnetic complexes, lanthanide coordination chemistry, responsive contrast agents, CEST agents, thermodynamic stability and kinetic inertness of complexes, multimodal and theranostic contrast agents
Magnetic Resonance Imaging (MRI) is one of the most powerful techniques used in clinical diagnostics and biomedical research. Due to the low sensitivity of MRI, the development of MRI contrast agents is a very active and wide field of research. There is a high diversity in the objects studied, ranging from small complexes to nanoparticles; the type of contrast agent, T1, T2 or Chemical Exchange Saturation Transfer (CEST); and their applications. The contrast agents in clinical use today are mainly non-specific. For better and early detection of diseases, targeted and responsive probes (which are selectively activated by a specific biomarker) are gaining increasing interest. Moreover, the combination of MRI and other imaging techniques enables to gain complementary information, and requires the development of multimodal probes. Finally, theranostic agents, that combine diagnostics and therapy in a single entity, represent a whole new area of development. This Special Issue aims to highlight the diversity of MRI contrast agents in terms of chemical structure and broad field of applications.
Dr. Célia S. Bonnet
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Inorganics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- molecular imaging
- paramagnetic complexes
- CEST agents
- Responsive contrast agents
- Targeted contrast agents
- Bimodal contrast agents
- Theranostic agents